-
BMB Intern Honored by Millipore Sigma
Congratulations to Dr. Rudra Palash Mukherjee, a former graduate student of our collaborator Dr. Beitle and a student intern for Boston Mountain Biotech. Rudra was selected as one of the four finalists for the Millipore Sigma’s 2016 Life Science Award in Bioseparations...
Read More -
BMB Awarded an NSF Phase I STTR
The National Science Foundation (NSF) has awarded Boston Mountain Biotech a Phase I STTR (small business technology transfer) commercialization grant for the “Harnessing CRISPR-mediated silencing for the one-step optimization of protein production strains”.
Read More -
Research Services for Biotech Companies
Custom batch fermentation services, medium formulation and optimization, storage of cell lines, propagation of bacterial or yeast cells, expression and purification of proteins, plasmid vector construction, isolation, and more.
Read More -
Simplifying Science and Scale-up
Early stage commercialization assessments help you determine the patentability and marketability of your technologies, saving you money and increasing your success rate. Work with us from setting a timeline to product launch to forming a go-to-market strategy.
Read More
"Accelerate with Lotus® technology."
services and platforms to speed innovation to market
Boston Mountain Biotech
Boston Mountain Biotech is a contract research organization focused on developing technology to simplify the scale-up of pharmaceutical manufacturing. The Lotus® technology allows manufacturers to reduce host cell protein (HCP) load in downstream processing through cell line modifications and simplify the development and manufacturing of recombinant protein therapeutics, vaccines and enzymes.
Research Services
Boston Mountain Biotech provides services from upstream cell line development to downstream protein purification.
It is our mission to support scientists by allowing them to focus on what they do best while we take care of the rest. Our facilities are equipped to handle both the small scale needs of academic and clinical researchers as well as the larger scale needs of research teams entering pre-IND development.
Lotus® Cell Line Optimization
The Lotus® platform links downstream contaminating host cell proteins (HCPs) to potential upstream cell line modifications, causing a boost in chromatographic efficiency. This allows manufacturers to shorten their development time while having a minimal impact on equipment and FDA approval.